Related Experiment Video
Updated: Jun 15, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
Ke Guo1, Miao Lu1, Jianlei Bi2
1Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Abstract:
Ovarian cancer is currently the second most common malignant tumor among gynecological cancers worldwide, primarily due to challenges in early diagnosis, high recurrence rates, and resistance to existing treatments. Current therapeutic options are inadequate for addressing the needs of ovarian cancer patients. Ferroptosis, a novel form of regulated cell death with demonstrated tumor-suppressive properties, has gained increasing attention in ovarian malignancy research. A growing body of evidence suggests that ferroptosis plays a significant role in the onset, progression, and incidence of ovarian cancer. Additionally, it has been found that immunotherapy, an emerging frontier in tumor treatment, synergizes with ferroptosis in the context of ovarian cancer. Consequently, ferroptosis is likely to become a critical target in the treatment of ovarian cancer.
Insights
Ferroptosis, a cell death process, shows promise in treating ovarian cancer by overcoming treatment resistance. Combining ferroptosis with immunotherapy may offer new therapeutic strategies for this common gynecological malignancy.
Area of Science:
- Oncology
- Cell Death Research
- Cancer Therapeutics
Background:
- Ovarian cancer is a leading gynecological malignancy with poor outcomes due to diagnostic challenges, recurrence, and treatment resistance.
- Existing therapies for ovarian cancer are insufficient, highlighting the need for novel treatment approaches.
- Ferroptosis, a regulated form of cell death, exhibits tumor-suppressive capabilities and is increasingly recognized for its role in ovarian cancer.
Purpose of the Study:
- To explore the role of ferroptosis in ovarian cancer development and progression.
- To investigate the potential synergistic effects of ferroptosis and immunotherapy in ovarian cancer treatment.
- To establish ferroptosis as a potential therapeutic target for ovarian cancer.
Main Methods:
- Review of existing literature on ferroptosis and ovarian cancer.
- Analysis of studies investigating the mechanisms of ferroptosis in gynecological malignancies.
- Examination of preclinical and clinical data on ferroptosis-inducing agents and immunotherapy combinations.
Main Results:
- Ferroptosis is implicated in the initiation, progression, and incidence of ovarian cancer.
- Evidence suggests that ferroptosis can enhance the efficacy of immunotherapy in ovarian cancer models.
- Ferroptosis induction presents a promising strategy to overcome therapeutic resistance in ovarian cancer.
Conclusions:
- Ferroptosis plays a significant role in ovarian cancer pathogenesis and progression.
- The combination of ferroptosis and immunotherapy demonstrates synergistic anti-tumor effects in ovarian cancer.
- Targeting ferroptosis represents a promising new avenue for ovarian cancer treatment, potentially improving patient outcomes.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Related Concept Videos
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:07Oogenesis